Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 51 (6), e13267

Double-blind, Randomised, Placebo-Controlled Trial on the Effect of L-carnitine and L-acetylcarnitine on Sperm Parameters in Men With Idiopathic Oligoasthenozoospermia

Affiliations
Randomized Controlled Trial

Double-blind, Randomised, Placebo-Controlled Trial on the Effect of L-carnitine and L-acetylcarnitine on Sperm Parameters in Men With Idiopathic Oligoasthenozoospermia

Sava Micic et al. Andrologia.

Abstract

Carnitine is essential for energy metabolism and spermatozoa maturation. Combining L-carnitine and L-acetylcarnitine with micronutrients has been investigated as a treatment for infertility in men. We evaluated the effects of a therapeutic formulation, Proxeed Plus, on sperm parameters in oligoasthenozoospermic men. This prospective, randomised, double-blind, placebo-controlled clinical trial involved 175 males (19-44 years) with idiopathic oligoasthenozoospermia who failed to impregnate their partners (12 months). Males received Proxeed Plus or placebo for 3 and 6 months. Sperm volume, progressive motility and vitality significantly (p < 0.001) improved after 6 months compared to baseline. Sperm DNA fragmentation index significantly decreased compared to baseline (p < 0.001) and the 3-month therapy (p = 0.014) in treated men. Increased seminal carnitine and α-glucosidase concentration also positively correlated with improved progressive motility. Decreased DNA fragmentation index was the good predictor of progressive sperm motility >10%, and simultaneous measurement of changes in sperm vitality and DNA fragmentation index gave the highest probability of sperm motility 10% (AUC = 0.924; 95% CI = 0.852-0.996; p < 0.001). Logistic regression analyses revealed DNA fragmentation index decrease as the only independent predictor of sperm motility 10% (OR = 1.106; p = 0.034). We have demonstrated the beneficial effects of carnitine derivatives on progressive motility, vitality and sperm DNA fragmentation. Combining metabolic and micronutritive factors is beneficial for male infertility.

Keywords: L-acetylcarnitine; L-carnitine; male infertility; oligoasthenozoospermia; sperm parameters.

Similar articles

See all similar articles

Cited by 3 PubMed Central articles

References

    1. Abdelrazik H., Sharma R., Mahfouz R., & Agarwal A. (2009). L-carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos. Fertility and Sterility, 91(2), 589–596. - PubMed
    1. Adiga S. K., Jayaraman V., Kalthur G., Upadhya D., & Kumar P. (2008). Declining semen quality among south Indian infertile men: A retrospective study. Journal of Human Reproductive Sciences, 1(1), 15–18. 10.4103/0974-1208.38972 - DOI - PMC - PubMed
    1. Agarwal A., Majzoub A., & Esteves S. C. (2016). Clinical utility of sperm DNA fragmentation testing: Practice recommendations based on clinical scenario. Translational Andrology and Urology, 5, 935–950. - PMC - PubMed
    1. Agarwal A., Mulgund A., Hamada A., & Chyatte R. (2015). A unique view on male infertility around the globe. Reproductive Biology and Endocrinology, 13, 37. - PMC - PubMed
    1. Agarwal A., & Said T. M. (2004). Carnitines and male infertility. Reproductive BioMedicine Online, 8(4), 376–384. 10.1016/S1472-6483(10)60920-0 - DOI - PubMed

Publication types

LinkOut - more resources

Feedback